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Background: Influenza virus undergoes rapid evolution by both antigenic shift and antigenic drift. Antibodies,
particularly those binding near the receptor-binding site of hemagglutinin (HA) or the neuraminidase (NA) active
site, are thought to be the primary defense against influenza infection, and mutations in antibody binding sites can
reduce or eliminate antibody binding. The binding of antibodies to their cognate antigens is governed by such
biophysical properties of the interacting surfaces as shape, non-polar and polar surface area, and charge.
Methods: To understand forces shaping evolution of influenza virus, we have examined HA sequences of human
influenza A and B viruses, assigning each amino acid values reflecting total accessible surface area, non-polar and
polar surface area, and net charge due to the side chain. Changes in each of these values between neighboring
sequences were calculated for each residue and mapped onto the crystal structures.
Results: Areas of HA showing the highest frequency of pairwise changes agreed well with previously identified
antigenic sites in H3 and H1 HAs, and allowed us to propose more detailed antigenic maps and novel antigenic
sites for H1 and influenza B HA. Changes in biophysical properties differed between HAs of different subtypes, and
between different antigenic sites of the same HA. For H1, statistically significant differences in several biophysical
quantities compared to residues lying outside antigenic sites were seen for some antigenic sites but not others.
Influenza B antigenic sites all show statistically significant differences in biophysical quantities for all antigenic sites,
whereas no statistically significant differences in biophysical quantities were seen for any antigenic site is seen for
H3. In many cases, residues previously shown to be under positive selection at the genetic level also undergo rapid
change in biophysical properties.
Conclusions: The biophysical consequences of amino acid changes introduced by antigenic drift vary from subtype
to subtype, and between different antigenic sites. This suggests that the significance of antibody binding in
selecting new variants may also be variable for different antigenic sites and influenza subtypes.Background
Influenza virus undergoes rapid evolution in nature by both
genetic shift, where one (or more) of the eight gene seg-
ments is exchanged from one virus into another [1], and
genetic drift, whereby mutations accumulate in viral genes
[2], presumably due to the relatively error-prone replication
of the viral RNA. This presents a significant challenge for
vaccine design, as new vaccines must be produced almost
every year in order to provide the best match with viruses* Correspondence: sstray@umc.edu
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distribution, and reproduction in any mediumlikely to circulate in the coming influenza season. While
other potential targets for vaccination to protect against in-
fluenza infection are under investigation [3,4], it is likely
that vaccines based on the intact surface proteins of influ-
enza viruses will remain in use for the foreseeable future.
The activities of both hemagglutinin (HA) and neuraminid-
ase (NA) are essential to viral function, and antibodies rec-
ognizing HA and NA are the primary defense against viral
infection [5]. Antibodies binding near the receptor-binding
site of HA [6,7] or the substrate binding site of NA [8,9]
strongly inhibit viral function, so it is presumed that muta-
tions in these binding sites which reduce or eliminate anti-
body binding confer a significant evolutionary advantage.ed Central Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lates and the selection of “escape mutant” variant viruses
resistant to neutralizing monoclonal antibodies have
allowed the delineation of critical neutralizing antigenic
sites in both HA and NA [7]. In many cases, a single
amino acid change is sufficient to reduce, often drastic-
ally, the neutralizing effect of antibody. Studies of inter-
actions between mutant influenza NA and monoclonal
antibodies at the biochemical and structural level have
revealed at least two classes of binding phenomena; for
some antibody-antigen pairs, the contribution of some
amino acids is much more important than others in the
epitope, presumably because interactions with these
amino acids contribute much more to the antibody bind-
ing energy [10,11], while for other antibody-antigen
pairs, the contribution of each amino acid in the epitope
is approximately similar [12,13], suggesting that consid-
erations such as shape complementarity between the
binding site on the antibody and the antigenic site is crit-
ical to antibody binding. Biophysical analyses of antigen/
antibody pairs consisting of either lysozyme and mono-
clonal antibody or idiotype/anti-idiotype monoclonal
antibody pairs suggest that epitopes that are tightly
bound by antibody may often have a hydrophic core sur-
rounded by hydrophilic amino acids, suggesting that
both entropy and electrostatics are important in antibody
binding (reviewed in [14]). It should be noted the total
number of antibody/antigen pairs that have been ana-
lyzed at the biophysical level remains small, so any
generalization must be made with caution.
As first suggested by Darwin [15], evolution is presum-
ably governed by a complex interplay between positive
selection for a novel function, such as a new enzyme spe-
cificity or escape from antibody binding, and negative se-
lection against those changes which have a deleterious
effect on the protein’s structure or critical functions or
interactions. To begin to understand the forces shaping
the evolution of influenza virus HA, we have examined
HA sequences available in the National Center for Bio-
technology Information (NCBI) Influenza Database [16].
We reasoned that, if ongoing selection by neutralizing
antibodies is important, those residues targeted by neu-
tralizing antibody will continually change over time.
Thus, we have made pairwise comparisons between
aligned sequences to look for changes in closely related
HAs. We have both quantitated the frequency of change
of individual amino acids, and attempted to understand
how these changes affect the biophysical properties of in-
dividual residues within HA. Our studies indicate that
the types of changes observed at different antigenic sites
vary between influenza subtypes, and between individual
antigenic sites in the same HA. We also demonstrate
that many HA residues shown by others to be under
positive selection at the genetic level [17,18] also have apropensity to undergo changes in biophysical properties.
These data may prove useful in developing algorithms to
better predict future changes in influenza antigens to im-
prove influenza vaccine design.
Methods
Influenza sequences and sequence alignments
Amino acid sequences for the HA1 domain of HA from
human clinical H1N1 (n = 531, 1918–2008, i.e. excluding
2009 “Swine-origin” pandemic isolates), H3N2 (n = 968,
1968–2005), and influenza B (n = 209, 1940 – 2007,
alignments performed without separating out Victoria
and Yamagata lineages). Due to the fact that many
sequences did not contain complete sequence data for
the HA2 portion of the molecule, analyses were per-
formed solely for the HA1 portion. Amino acid
sequences were obtained and a best fit alignment per-
formed using MUSCLE [19], as implemented in the
NCBI Influenza Virus Resource (http://www.ncbi.nlm.
nih.gov/genomes/FLU, [16]). Incomplete and duplicate
sequences were removed prior to alignment where pos-
sible. See Additional file 1 for sequence alignments used
in this study.
Pairwise comparison of aligned sequences
Aligned sequences from NCBI were uploaded into
Kalignvu (http://msa.sbc.su.se/cgi-bin/msa.cgi, [20]) to
produce a dataset containing complete amino acid
sequences which were then uploaded into Excel (Micro-
soft, Renton WA). The absolute number of pairwise
changes at each position was determined and divided by
the total number of sequences. This was designated
Δabs, and represents the frequency of any amino acid
change at a given position. Note that, under this ap-
proach, a single change from the root sequence which is
then perpetuated throughout the rest of the sequences in
the alignment will have a low value for Δabs, whereas a
position where different amino acids can occur in differ-
ent sequences will have a much higher Δabs.
Parameterization and calculation of change in biophysical
properties
Each amino acid in the dataset was then assigned values
for ΔASAtot, ΔASAnp, and ΔASApol (Table 1, [21,22]).
Each amino acid was also assigned a value for net charge
at pH 7.0 (Q, Table 1) based on the side chain pKa, with
completely ionized acidic and basic residues being
assigned values of −1 and +1, respectively. For every resi-
due in HA, pairwise changes in each parameter were cal-
culated by subtracting the assigned value from that at
the same position in the sequence immediately above it
in the alignment table (i.e. the most closely related se-
quence). The absolute values of these differences were
averaged for the same position in all sequences in the
Table 1 Values for parameters assigned to each amino acid
aa A R N D C Q E G H I L
ΔASAtot
a 54.6 199.6 112.9 99.4 92 122.3 124.5 0 144.9 135.9 143.8
ΔASAnp 62.9 85.3 28.5 42.2 40.8 46.7 55.9 25.7 99.5 139.5 144.4
ΔASApol 28.7 151.3 113.3 87 96.1 110.1 103.6 28.7 74.1 28.7 28.7
Qb 0 1.00 0 −1.00 −0.11 0 −1.00 0 0.05 0 0
aa K M F P S T W Y V Deleted/missingc
ΔASAtot 155.6 158 172 90.7 71.7 105.4 222.4 190.2 105.6 300
ΔASAnp 122.4 122.1 172 100.8 44.2 74.8 200.5 154.3 113 258.3
ΔASApol 70.3 73 28.7 15.6 64.4 63.4 52.4 71.6 26.2 64.4
Q 1.00 0 0 0 0 0 0 0 0 0
aValues for ΔASAtot, ΔASAnp, and ΔASApol as in [21]. Note that values for ΔASAtot are all based on comparison to the surface area of glycine, which is set to 0.
bCalculated at pH 7.0, setting completely ionized acids and bases at −1.00 and 1.00, respectively.
cValues for deleted or missing amino acids were chosen arbitrarily.
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Normalized Change Index (NCI) values for ΔΔASAtot,
ΔΔASAnp, ΔΔASApol and ΔQ. Thus, in cases where no
change was observed between the two sequences, the
numerical value of the difference was zero, but where a
difference occurred, the value represents the average
magnitude of the difference every time a change occurs.
Because of the normalization to Δabs, a frequently oc-
curring conservative change can be readily distinguished
from a rarer, non-conservative change. Values for Δabs,
ΔΔASAtot, ΔΔASAnp, ΔΔASApol and ΔQ for each amino
acid position in HA were analyzed statistically to deter-
mine the median, 75th percentile and 90th percentile
values for each dataset using Kaleidagraph (Synergy Soft-
ware). Rapidly changing residues were defined as those
residues in the 75th percentile and above in terms of
Δabs.Structural analysis, assignment of antigenic sites, and
statistical analysis
To allow comparison of changes in biophysical para-
meters with previously defined antigenic sites and the re-
ceptor binding pocket, amino acid residues in the crystal
structures of H1, H3, and influenza B HA were color-
coded to represent NCI values for biophysical para-
meters (see individual figure legends for structures used
in each case), using Mac PyMol (DeLano Scientific LLC).
Rapidly changing residues (Δabs ≥ 75th percentile) were
color-coded based on whether the NCI value of interest
fell below the median, was between the 50th and 75th
percentile, between the 75th and 90th percentile, or above
the 90th percentile for HA1 residues in terms of NCI
values for ΔΔASAtot, ΔΔASAnp, ΔΔASApol and ΔQ. See
figure legends for further details.
Rapidly changing amino acids on the outer surface of
the respective HA1 monomers formed surface patches
roughly analogous to the previously described neutralizingantigenic sites of H1, H3, and B HA antigenic sites, and
were deemed to belong to these antigenic sites. The prop-
erties of these antigenic sites were compared statistically
by comparing the value of each parameter for all the resi-
dues assigned to a particular antigenic site to a dataset
comprising all amino acids from the HA1 portion of the
same HA molecule not assigned to antigenic sites (non-
antigenic site residues). It is assumed that non-antigenic
site residues include both amino acids that cannot be
altered without deleterious effects on structure or function
and residues subject to genetic drift but where antibody-
mediated selection is unlikely to occur. The majority of
non-antigenic site residues undergoing rapid change are
on solvent-exposed surfaces not likely to be accessible to
antibody, such as on the back of the monomer. Statistical
comparisons were performed using Kruskal-Wallis
ANOVA with Dunn’s post- test (GraphPad Prism).Effect of alignment on biophysical parameters
To test for potential biases due to a particular method of
alignment, and any effect of potential alignment error,
We generated a dataset to represent each sequence com-
posed of antigenic site residues paired with a set of ran-
domly selected residues for the HA1 region of each HA.
These amino acids were extracted from each sequence,
then the datasets containing the extracted residues
representing each sequence were re-organized such that
each dataset (representing a single sequence), now had
new “nearest neighbors” in the data table. Values for
Δabs, ΔΔASAtot, ΔASAnp, ΔΔASApol, and ΔQ were
recalculated for each amino acid in the dataset based on
the new arrangement of sequences. The epitope residues
for each HA were paired with datasets of randomly
chosen residues. This resorting process was carried out
twenty times to achieve a partially randomized arrange-
ment of datasets. Statistical comparisons between the
parameter values for the antigenic site amino acids and
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the original alignments and the resorted datasets using
Kruskal-Wallis ANOVA with Dunn’s post- test.
Results and discussion
Sequence alignment and parameterization
Amino acid sequences were aligned using the multiple
protein sequence alignment tool MUSCLE. Since we
wish to test the hypothesis that antibody selection is a
key player in virus evolution, and this acts at the protein
level, we elected to align amino acid rather than nucleic
acid sequences, An alignment algorithm based on pair-
wise sequence comparison was chosen over other
approaches because we wished to compare sequences on
the basis of pairwise differences in values reflecting
amino acid properties, and we reasoned that sequences
aligned in such a fashion to minimize pairwise differ-
ences, as is the case with MUSCLE, would provide the
most conservative approach, although we cannot rule
out the possibility that potentially important sequence
differences might be obscured. Amino acids in the align-
ment tables were then parameterized based on one of
four properties: side chain size (measured by solvent-ac-
cessible surface area), hydrophobicity (measured by solv-
ent-accessible non-polar surface area), hydrophilicity
(measured by solvent-accessible polar surface area), or
side-chain charge. Values pertaining to each property of
interest were then compared mathematically to deter-
mine whether there was any trend in changes at a par-
ticular site in the protein (see Methods).
Prediction of novel sites in potential antigenic sites in H1
and B HA
Neutralizing antigenic sites have been described for human
H1 [23,25], H3 [7,26], and influenza B [24] HA. For each
HA, we calculated the average number of changes between
neighboring aligned sequences (Δabs), and mapped these
on to the surfaces of HA structures (Figure 1). There is rea-
sonably good agreement between the previously described
antigenic sites and residues with high Δabs values, espe-
cially those in the top 25th percentile range (red and orange
residues in Figure 1a). This is particularly true for H3, the
human influenza HA best characterized at the antigenic
level. Residues in each of the previously described H3 HA
antigenic sites (A-E) are represented in the residues with
the highest Δabs values (Figure 1a, Table 2), suggesting that
pairwise sequence analysis for determining frequencies of
change is a useful method for predicting residues that may
be evolving in response to antibody selection. Somewhat
unexpectedly, we also find rapidly changing residues on the
rear face of the monomer, which would not be expected to
be accessible to antibody, at least in the neutral pH con-
formation. Two of these residues, amino acids 220 and 229,
have been shown to be under positive selection at thegenetic level based on comparing rates of synonymous and
non-synonymous nucleotide substitutions [17].
When Δabs values were mapped onto the surface of
the influenza H1 HA monomer from crystal structure
and compared to antigenic sites described for A/Puerto
Rico/8/34 (H1N1, Figure 1a), there is good agreement
between residues showing high Δabs values and the pre-
viously identified Sb and Sa antigenic sites on the top of
the HA molecule ([23,25], yellow and orange, respect-
ively), roughly akin to the B antigenic site of H3 HA.
The Ca2 antigenic site, below the receptor binding site
(RBS), structurally analogous to the A site in H3 (blue in
Figure 1a), shows some overlap with residues in this re-
gion showing high Δabs values, but higher values are
seen for neighboring residues that form part of a prom-
inent projection immediately below the RBS. Overlap
with the remaining previously-described H1 antigenic
sites, Ca1 and Cb (olive and red in Figure 1a) is less ex-
tensive. Additionally, high Δabs values predict an add-
itional antigenic site composed of shelf-like projection
below the Cb antigenic site, analogous to the C antigenic
site in H3. For ease of further discussion, we will refer to
this as H1C. We note that a somewhat similar antigenic
site in H1 HA has been reported elsewhere [27]. Resi-
dues assigned to each antigenic site are listed in Table 2.
As for H3, H1 residues at the rear of the monomer are
also changing relatively rapidly, and one of these, amino
acid 98, has shown to be positively selected [18]. Strik-
ingly, differences in Δabs values between the Sa anti-
genic site on the top of the H1 monomer and non-
antigenic site residues are not statistically significant,
suggesting that the rate of change at this antigenic site is
not high, even though the loss of a glycosylation site at
this antigenic site seems to be a critical antigenic differ-
ence between “seasonal” H1N1 strains circulating be-
tween 1977 and 2008, and the pandemic “Swine-origin”
2009 H1N1 strains [28], possibly because this site might
be constrained to preserve some unknown function. All
other antigenic sites described are statistically signifi-
cantly different from non-antigenic site residues in terms
of Δabs values.
When compared to a previous antigenic map of B HA
[24], residues with high Δabs values match well with the
best defined antigenic site, analogous to the influenza A
H3 B and H1 Sb antigenic sites, lying above the RBS.
Antigenic sites analogous to the H3 B, D, and E antigenic
sites were previously defined, some by as few as three
residues. Based on high Δabs, our studies support the ex-
istence of important antigenic determinants in these
areas of the molecule, and suggest the existence of two
additional antigenic sites on influenza BHA. One is
found on a shelf-like structure below the previously-
described E antigenic site, analogous to the H3C and
H1C sites. For ease of discussion, we will refer to this as
Figure 1 Influenza HA antigenic sites. (a) Comparison of previously described antigenic sites in influenza H1 H3, or B HA. For each HA, the
structure to the left shows the previously defined antigenic site residues mapped onto a monomer an appropriate crystal structure, while the
structure on the right shows residues colored according to the frequency of absolute change (i.e. any amino acid substituted with any other) in
comparison with the same residue in the most closely related sequence (abs, see Materials and Methods, color code shown in panel b), viewed
from the top (T) or side (S). The H1 structure shows antigenic residues [23] mapped onto the 3D structure of A/Puerto Rico/8/24 HA (PR8, PDB ID:
1RU7). Color scheme for antigenic sites: Ca1, olive; Ca2, blue; Sb, yellow; Sa, orange; Cb, red, as indicated by labels on the structure. Neutralizing
antigenic sites [7] of influenza A H3 HA monomer mapped onto the crystal structure of A/X-31 HA (PBD ID: 2VIU). Color scheme: antigenic site A,
blue; B, yellow; C, red; D, orange; E, magenta Antigenic sites in influenza B HA [24] mapped onto the 3D structure of B/Lee/40 HA (PDB ID: 1RFT),
viewed from the top (T) or side (S). Color scheme: antigenic site A, blue; B, yellow; c, red; D, orange; E, magenta; base of receptor binding pocket,
purple. (b) Color scheme indicating frequency of change: frequency below 50th percentile of all residues in HA1, white; between 50th and 75th
percentile, green; between 75th and 90th percentile, orange; 90th percentile and above, red. (c). Views of H1, H3, and influenza B HA monomers
from behind. (d) Crystal structure of H3 HA trimer (PBD ID: 2VIU), viewed from the top, the side, and along the intratrimer axis, shown for
orientation.
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addition to the previously described H3 B-like antigenic
site, adjacent to this we observe a putative novel anti-
genic site analogous to the Sa site in H1. For ease of fur-
ther discussion, we will refer to these as BB1 and BB2
antigenic sites, respectively. The BB1 antigenic site con-
sists of a “knob” of residues above the RBS, while BB2
consists mainly of a ridge of rapidly changing residues
across the top of the molecule.
Site-specific differences in biophysical properties in H1 HA
When biophysical properties of those residues in H1 under-
going most frequent changes (Δabs values in the 75th per-
centile and above) were examined, there are quite strikingdifferences between different antigenic sites. Changes in NCI
values for ΔΔASAtot for the Ca2, Sb, Sa, and H1C antigenic
sites were not statistically significant compared to changes in
NCI values for ΔΔASAtot for non-antigenic site residues in
H1 HA (Figure 2, Table 3), suggesting that volume occupied
by individual amino acids, and hence the shape of the sur-
face in these regions associated with antibody binding, is
relatively conserved. This suggests that the overall shape of
these antigenic sites is not particularly important in antibody
recognition, and so changes to the shape of the antigenic site
do not confer a selective advantage. Alternatively, the shape
of the antigenic site must be conserved to prevent loss of
some other important function, such as binding of cell sur-
face receptors or a putative co-receptors [29]. In contrast,
Table 2 Amino acids assigned to antigenic sites
H1a


































155, 156, (157), 158–60, 186,
188–9, (190), 192, 193, (194),































71, 73, 75, 76
aH1 numbered according to the amino acid position in A/Puerto Rico/8/34/Mount Sinai.
bResidues showing rates of change in the top 25% of all residues were assigned to previously described epitopes [7,23,24].
cNot defined in prior studies.
dAmino acid 132a deleted in A/Puerto Rico/8/34/Mount Sinai, but present in other strains prior to 1997.
eResidues assigned to this epitope in this work only are italicized.
fResidues assigned to this epitope in this work and in previous studies are underlined.
gResidues assigned to this epitope in previous studies not meeting our inclusion criteria are enclosed in parentheses.
hH3 HA residues numbered as for mature HA1 of A/Aichi/2/1968.
iInfluenza B HA residues numbered as for B/Lee/40.
jPrevious studies define a single epitope at the top of influenza B HA [24], but we have elected to divide this into two based on apparent functional differences
based on the pattern of biophysical changes we observe.
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did show statistically significant changes in ΔΔASAtot NCI,
suggesting that changes in the shape of the surface in this re-
gion is at least tolerated, if not advantageous due to disrup-
tion of antibody binding. The Ca1 antigenic site is close to
the trimer interface, so changes in shape might alter interac-
tions between monomers, potentially affecting stability and
influencing the pH of the transition to the fusion-active con-
formation. No significant changes in ΔΔASAnp NCI are
found in any of the H1 HA antigenic sites. The H1C and Cb
sites show significant differences in changes in NCI values
for ΔΔASApol, and the Ca2 antigenic site shows significant
differences in ΔQ compared to non-antigenic site residues in
HA1.
Biophysical properties of frequently changing H3 residues
Sequences of HA genes from 958 human H3N2 influ-
enza isolates were analysed as described above (Figure 3,
Table 2-3). Unlike H1, we did not observe statistically
significant differences in ΔΔASAtot, ΔΔASAnp, or
ΔΔASApol NCI between any of the H3 antigenic sites
and non-antigenic site residues. Although the potentialimportance of charge in evolution of H3 antigenic sites
has also been recently suggested [30], we did not find
statistically significant differences in ΔQ between rapidly
changing residues and non-antigenic site residues for any
H3 antigenic site. Strikingly, some of the least conserva-
tive changes occur in residues within antigenic site D
and at the rear of the trimer (Figure 1d), in areas of the
molecule at least partially occluded by the neighboring
monomer in the 3D structure. It has been suggested that
these changes affect antibody binding at a distance by
changing the conformation at the surface [26]. Other
studies demonstrate that the trimer may adopt a more
open conformation than seen in the crystal structures at
least transiently, exposing these residues to antibody
[31]. Thus, changes in the region of the trimer interface
may act to increase or decrease the stability of the trimer,
and covariation of residues interacting in the interface
between neighboring monomers might be expected to
occur. Alternatively, the rate of change of residues
expected to be occluded based on the crystal structure
may represent a background rate of amino acid change,
and that all areas of the molecule undergoing change at
Figure 2 Biophysical characteristics of influenza H1 HA antigenic sites. (a) Rates of change at individual residues in H1 HA are shown from
the top (T) and viewed along the left (L) and right (R) sides of the monomer. Note that structures marked T and L in panel a are identical to the
structures marked “abs” in the leftmost section of Figure 1a with approximate positions of antigenic sites Ca1, Ca2, Cb, Sa, Sb, and H1C (see
Table 2) indicated with white labels. Color-coding of surface residues is as described in Figure 1b. The most rapidly changing residues in H1 HA
(75th percentile and above; red and orange in panel A) were color-coded according to the average pairwise change in NCI values for ΔΔASAtot (tot,
panel b), ΔΔASAnp (np, panel c), ΔΔASApol (pol, panel d), or ΔQ (ch, panel e). (f) Color scheme for panels b-e: residues whose absolute rate of change
is lower than the 75th percentile, white, residues in the top 25th percentile in terms of absolute amino acid changes but whose change in the
value of interest was below the 50th percentile of all residues in HA1, blue; values between 50th and 75th percentile, green; values between 50th
and 90th percentile, orange; values above 90th percentile, red. Structure files used to generate panels a-e, viewable using PyMol, are available on
line (Additional files 2, 3, 4, 5 and 6).
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maintain important functions such as interaction with al-
ternate receptors or putative co-receptors [29,32].
Differences in biophysical properties define separate
adjacent antigenic sites in B HA
HA genes from 209 influenza B isolates were also
studied (Figure 4, Tables 2-3). Unlike influenza A H1and H3 HAs, NCI values for ΔΔASAtot, ΔΔASAnp,
ΔΔASApol, and ΔQ are significantly different between
each of the antigenic sites residues and non-antigenic
site residues for all but ΔΔASApol NCI values at anti-
genic site BE. These findings suggest that changes in
BHA antigenic sites may be more likely to confer se-
lective advantage than those occurring in H1 and H3
HAs.
Table 3 Statistical comparison of antigenic sites to non-antigenic residues
Antigenic
Sitea
pb antigenic site vs. non-antigenic site residues
Δabs ΔΔASAtot ΔΔASAnp ΔΔASApol ΔQ
H1
Ca2 p< 0.01 NS NS NS p< 0.05
Sb p< 0.001 NS NS NS NS
Sa NS NS NS NS NS
H1C p< 0.001 NS NS p< 0.05 NS
Ca1 p< 0.05 p< 0.001 NS NS NS
Cb p< 0.001 p< 0.05 NS p< 0.01 NS
H3
A p< 0.001 NS NS NS NS
B p< 0.001 NS NS NS NS
C p< 0.001 NS NS NS NS
D p< 0.001 NS NS NS NS
E p< 0.01 NS NS NS NS
B
BA p< 0.001 p< 0.001 p< 0.001 p< 0.001 p< 0.01
BB1 p< 0.001 p< 0.01 p< 0.001 p< 0.01 p< 0.001
BB2 p< 0.001 p< 0.01 p< 0.001 p< 0.01 p< 0.01
BC p< 0.001 p< 0.01 p< 0.01 p< 0.01 p< 0.05
BD p< 0.001 p< 0.001 p< 0.001 p< 0.001 p< 0.01
BE p< 0.001 p< 0.05 p< 0.01 NS p< 0.05
aSee Table 2.
bStatistics: Kruskal Wallis one-way ANOVA (non-parametric) with Dunn’s post-test.
cNon-antigenic site residues are all residues in HA1 not assigned to a particular antigenic site.
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dependent on alignment
To determine whether our findings were dependent
upon the quality of the sequence alignment, NCI values
for antigenic site residues were compared to a randomly
chosen set of ten residues from the same HA (Table 4).
The tables of sequences, with each sequence now repre-
sented by a dataset comprising the antigenic site residues
(Table 2) and the randomly chosen residues, were then
rearranged such that each sequence dataset now had new
sequences as nearest neighbors, compared to its position
in the original alignment. NCI values for Δabs, ΔΔASAtot,
ΔΔASAnp, ΔΔASApol, and ΔQ were calculated for each
amino acid position before rearrangement, and after
twenty rounds of resorting, which we believe represents a
partial randomization of the sequence order. In many
cases, the degree of statistical significance differed between
the same datasets in the original alignment and following
partial randomization (Table 4). The fact that the statistical
significance is altered when the data obtained reflect an
alignment where the nearest neighbor sequences are not
necessarily the most closely related suggests both that our
analysis is yielding important information about changes
between the most closely related sequences, and that ourconclusions might be skewed if the alignment of sequences
is poor.
Comparison of changes in biophysical properties to other
techniques to identify evolutionarily important residues
We wished to compare our results to those of others who
have attempted to identify residues in influenza HA which
might have evolutionarily predictive value (Table 5, Figure 5).
A recent study of human seasonal H1N1 viruses identified
eight residues in HA1 which were apparently under positive
selection [18]. Of these, all but one residue is also found in
our dataset of amino acid residues (Table 2), and statistically
significant differences are found between this dataset and
the non-antigenic site residues from H1 HA1. Amino acid
98, the lone residue not assigned to an antigenic site in our
studies is highly variable, but found on the solvent-exposed
surface on the rear of the monomer. Studies of residues
which were changed in viruses forming new branches
within the H3N2 HA phylogenetic tree identified a group of
19 residues which seemed to be predictive of forming a new
branch [33]; of these, all but three are also assigned to anti-
genic sites in our study. Two of these (190 and 194) are ad-
jacent to the receptor binding site and do not change at
sufficiently high frequency to meet our inclusion criteria,
Figure 3 Biophysical characteristics of influenza H3 HA antigenic sites. (a) Rates of change at individual residues in H3 HA are shown from
the top (T) and viewed along the left (L) and right (R) sides of the monomer. Note that structures marked T and L in panel a are identical to the
structures marked “abs” in the middle section of Figure 1A, with approximate positions of antigenic sites A, B, C, D, and E indicated with white
labels. Color-coding of surface residues is as described in Figure 1b. The most rapidly changing residues in H1 HA (75th percentile and above; red
and orange in panel a) were color-coded according to the average pairwise change in NCI values for ΔΔASAtot (tot, panel b), ΔΔASAnp (np, panel c),
ΔΔASApol (pol, panel d), or ΔQ (ch, panel e). Color scheme for panels b-e as in Figure 2f. Structure files used to generate panels a-e, viewable using
PyMol, are available on line (Additional files 7, 8, 9, 10 and 11).
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lip of the monomer at the trimer interface. This dataset is
statistically significantly different from the H3 HA1 non-
antigenic site residues in terms of the absolute frequency of
amino acid change, but not in any other quantity examined.
We also compared our data to a dataset of sites in H3 HA1
undergoing directional selection, another means of identify-
ing accelerated substitutions at a specific site [34]. As for
the residues identified in [18] and [33], many of the residues
identified by this technique are also identified as antigenic
site residues in our analysis. Unlike the residues identified
by Bush et al. [33] and antigenic site residues from our
methodology, we observe statistically significant differences
between the dataset of directionally selected residues [34]
and non-antigenic site residues for both Δabs and NCIvalues for ΔQ. We note that a large number of amino acids
are invariant in our dataset, particularly in H1 and influenza
B. For those residues making critical structural interactions,
this is presumably the result of negative selection to main-
tain structural integrity, but for those residues on the sur-
face it is difficult to distinguish between the effects of
negative selection to maintain a previously unappreciated
function and the background rate of mutation in the ab-
sence of positive selection.
Role of alteration in biophysical properties in antibody-
mediated selection of variant viruses
Insights into the mechanism of antibody binding have
been derived from structural, biophysical, and bio-
chemical characterization of antibody-antigen pairs
Figure 4 Biophysical characteristics of influenza B HA antigenic sites. (a) Rates of change at individual residues in influenza B HA are shown
from the top (T) and viewed along the left (L) and right (R) sides of the monomer. Note that structures marked T and L in panel a are identical to
the structures marked “abs” in the rightmost section of Figure 1a, Approximate positions of antigenic sites BA, BB1, BB2, BC, BC, BD, and BE (see
Table 2) are indicated with white labels. Color-coding of surface residues is as described in Figure 1b. The most rapidly changing residues in H1
HA (75th percentile and above; red and orange in panel a) were color-coded according to the average pairwise change in NCI values for ΔΔASAtot
(tot, panel b), ΔΔASAnp (np, panel c), ΔΔASApol (pol, panel d), or ΔQ (ch, panel e). Color scheme for panels b-e as in Figure 2f. Structure files used to
generate panels a-e, viewable using PyMol, are available on line (Additional files 12, 13, 14, 15 and 16).
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http://www.virologyj.com/content/9/1/91[14], particularly for hen-egg lysozyme and anti-idioty-
pic antibodies (reviewed in [35]), and influenza A HA
(reviewed in [36]) and NA [10,13,37,38]. Changes in
shape of the antigenic sites due changes in the volumes
of individual side-chains were monitored by examining
ΔΔASAtot. Larger NCI values for ΔΔASAtot suggest that
an amino acid with a small side-chain surface area has
been replaced with a larger amino acid or vice-versa.
The biophysical quantities ΔΔASAnp, ΔΔASApol, and
ΔQ measure the propensity of residues to participate in
certain kinds of interactions. Charged residues will
interact with residues of opposite charge and be re-
pelled by residues of like charge. Charged and polar
residues can also participate in hydrogen bonding, ei-
ther with water molecules or with other proteins.Hydrophobic interactions between non-polar surfaces
are important in protein-protein interactions by con-
tributing to positive entropy to favor the energetics of
the bound state [22] and hydrophobic surfaces are a
feature of at least some antibodies showing evidence of
affinity maturation [35]. However, solvent-exposed
hydrophobic surfaces are energetically unfavorable.
Changes in shape may drive evolution of some antigenic
sites
Statistically significant changes in ΔΔASAtot NCI values
were seen for antigenic sites on the side of H1 HA (Cb
and Ca1) and for all antigenic sites described for influ-
enza B HA, but not for antigenic sites at the top of the
H1 HA (Sb and Sa) or at the trimer interface (Cb), or
Table 4 Effect of partial randomization of sequence dataset on antigenic site statistics
Antigenic
Sitea
pb from aligned sequencesc (pb from resorted sequencesd)
Δabs ΔΔASAtot ΔΔASAnp ΔΔASApol ΔQ
H1 epitope residues vs. randome
Ca2 p< 0.05 (NS) NS (NS) NS (NS) NS (NS) p< 0.05 (p< 0.05)
Sb p< 0.05 (p< 0.01) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
Sa NS (p< 0.05) NS (NS) NS (NS) NS (NS) NS (NS)
H1C p< 0.01 (p< 0.05) NS (NS) NS (NS) NS (NS) NS (NS)
Ca1 NS (NS) NS (p< 0.01) NS (NS) NS (NS) NS (NS)
Cb NS (NS) NS (NS) NS (NS) NS (NS) NS (NS)
H3 epitope residues vs. randomf
A NS (p< 0.05) NS (NS) NS (NS) NS (NS) NS (NS)
B p< 0.05 (p< 0.01) NS (NS) NS (NS) NS (NS) NS (NS)
C NS (NS) NS (NS) NS (NS) NS (NS) NS (NS)
D p< 0.05 (NS) NS (NS) NS (NS) NS (NS) NS (NS)
E NS (NS) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
B HA epitope residues vs. randomg
BA NS (p< 0.01) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
BB1 NS (p< 0.01) NS (NS) NS (p< 0.05) NS (NS) p< 0.001 (p< 0.05)
BB2 NS (p< 0.05) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
BC NS (NS) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
BD NS (NS) NS (NS) NS (NS) NS (NS) p< 0.05 (NS)
BE NS (NS) NS (NS) NS (NS) NS (NS) NS (NS)
aSee Table 2.
bProbability determined from comparison of antigenic site residues to randomly selected residues (see below) determined using Kruskal-Wallis ANOVA.
cAmino acid sequences aligned using MUSCLE. See Additional file 1 for resultant sequence alignment.
dAntigenic site residues, along with a set of randomly selected residues (below), were extracted from each sequence, then the datasets containing the extracted
residues representing each sequence were re-organized and Δabs, ΔΔASAtot, ΔΔASAnp, and ΔQ recalculated for each amino acid in the dataset based on the new
arrangement of sequences (see Methods).
eRandomly selected H1 residues: 2, 19, 23, 76, 84, 94, 117, 121, 178, 223, 301, 326.
fRandomly selected H3 residues: 12, 72, 111, 123, 139, 179, 222, 289, 312, 328.
gRandomly selected influenza B HA residues: 4, 17, 36, 47, 78, 152, 196, 222, 251, 273, 300, 304.
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NCI values we measured suggest that the shape of the
surface in the antigenic sites is altered significantly by
the accumulation of mutations for some antigenic sites,
and thus changes in the overall shape of these antigenic
site may contribute to escape from antibody binding.
For those antigenic sites not showing significant differ-
ences in ΔΔASAtot, such as the Sb and Sa antigenic
sites of on the top of H1, the shape of the surface may
be critical to maintaining other hitherto unappreciated
functions in virus binding or entry.
Changes in thermodynamic properties may influence
antibody escape
Statistically significant changes in ΔΔASAnp NCI values
were found for all antigenic sites in influenza B HA, and for
previously-described positively selected residues in H1 HA.
The fact that the influenza B HA antigenic sites have somehydrophobic character might indicate that they play some
other role in the function of HA, so there may be important
functional reasons for hydrophobic residues to be retained.
Antibody binding sites studied to date at the structural and
biophysical level seem to fall into at least two classes, the
first, where the antigenic site consists of a central core area
of hydrophobic residues, often surrounded by an outer ring
of hydrophilic amino acids, and a second where hydrophilic
residues and immobilized water molecules seem to play an
important role. In the first situation, so called “O-ring” epi-
topes, much of the binding energy is contributed by the in-
crease in entropy due to the liberation of the highly ordered
water molecules at the hydrophobic residues in both anti-
body and antigen. Thus, mutation of hydrophobic residues
in the antigenic site would be expected to reduce the bind-
ing energy of the antibody-antigen complex, as has be
shown in vitro [11,39]. We note that many of the positively
selected residues identified by Li et al., which as a group
Table 5 Changes in biophysical properties of positively-selected or “predictive” amino acids
































p< 0.001 NS NS NS p< 0.01
aSee [17].
bAmino acid numbers converted to conform to system described in Table 2.
cBolded numbers indicate that amino acid is defined as an epitope residue in our analysis (see Table 2).
dSolvent exposed at the rear of the H1 monomer.
eStatistical comparison to non-epitope residues from HA1 (Kruskal Wallis one-way ANOVA (non-parametric) with Dunn’s post-test).
fSee [33].
gReceptor binding site residue.
hSolvent exposed on edge of monomer.
iSee [34] Residues not in HA1 are excluded from this analysis.
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pared to non-antigenic site residues in H1 HA (Table 5),
are also identified in our study. These residues are mainly
found in the Ca2, Sb, and Sa antigenic sites. In the Sb, and
Sa antigenic sites, positively selected residues are clustered
together towards near center of our antigenic sites, suggest-
ing that these amino acids may act as the hydrophobic core
of “O-ring” like epitopes (Figure 2).
Biophysical and structural studies show that charge-
charge interactions (“salt bridges”) can make critical contri-
butions to both the extent and rate of antibody binding
[40], thus it is logical that changes in charge within an anti-
genic site may confer a selective advantage, as seen in the
H1 Ca2 and influenza B HA antigenic sites. The loss of a
critical charged residue would be expected to have a dele-
terious effect on both rate and extent of antibody binding,
and the gain of a novel charged residue could either prevent
antibody binding due to electrostatic repulsion or alter the
rate of binding by altering “electrostatic steering” required
for correct alignment of an antibody with its cognate anti-
genic site (see [41] for review).
Forces shaping evolution of influenza HA may vary
between subtypes and antigenic sites
Differences between the different HAs, and between
antigenic sites of the same HA molecule may suggest
that the “rules” for selecting changes at these sites maybe different. The rates of change of amino acid identity
were significant for all H3 and influenza B HA antigenic
sites compared to non-antigenic site residues, and for all
but the Sa antigenic site of H1 HA. This result is some-
what surprising, given that an important structural dif-
ference in this antigenic site between the pandemic
“Swine-origin” H1N1 influenza virus emerging in 2009
and prior seasonal H1N1 apparently played an important
role the susceptibility of the many people born after
1957 to the pandemic virus [28]. No statistically signifi-
cant changes in the other quantities studied were
observed for H3 HA, suggesting that the antibody reper-
toire against H3 HA, if responsible for selecting the
changes observed, is sufficiently discriminatory that even
highly conservative amino acid substitutions are suffi-
cient to confer a selective advantage. Interestingly, some
residues on the surface of HA monomer apparently
undergoing rapid change may not be antibody accessible,
at least based on the available crystal structures, suggest-
ing their evolution may be controlled by other factors.
This is particularly true of the rapidly changing residues
on the “rear” of the HA monomer, which would not be
expected to be solvent exposed in the neutral pH trimer
form, although there is good evidence to suggest that the
HA trimer is less rigid in vivo than expected from avail-
able crystallographic and electron microscopy data,
allowing the trimer structure to open and close [31].
Figure 5 Comparison of antigenic site residues with residues under positive selection. (a) Comparison of H1 antigenic site residues
described in this study (Table 2, color-coded as for Figure 1a) with residues positively selected in human H1N1 viruses [18] colored lime green.
(b) Comparison of H3 antigenic site residues described in this study (Table 2, color-coded as for Figure 1a except that the H1C epitope defined in
this study is shown in red) with residues predictive of novel lineages in human H3N2 viruses [33] colored lime green. To orient the reader, the
receptor binding site (RBS) has been labeled in purple. (c) Comparison of H3 antigenic site residues described in this study (Table 2, color-coded
as for Figure 1a) with directionally selected residues in human H3N2 viruses [34] colored lime green. Structure files showing epitopes, viewable
using PyMol, are available on line (Additional files 17 and 18).
Stray and Pittman Virology Journal 2012, 9:91 Page 13 of 16
http://www.virologyj.com/content/9/1/91These residues may vary simply because they are not
under negative selection since they would not be
expected to be required to participate in any of the
known functions of HA and are not involved in stabiliz-
ing its secondary, tertiary, or quaternary structure.
Possible implications for influenza evolution and
immunity
Our data raise several important issues in understanding
the function of influenza HA and the host immune system.
First, there appear to be important differences between evo-
lution of H3 HA and that of H1 and influenza B HA. This
suggests immune responses to H3 HA may be functionally
different from the immune responses to H1 and influenza
B. Differences in the role of antibody selection between in-
fluenza B and H3N2 viruses have been proposed previously
[42]. Our data suggest that even conservative structural or
biophysical changes in H3 HA antigenic sites may be suffi-
cient to confer a selective advantage. Influenza B and H1HAs may also be more subject to structural or functional
constraints, so fewer kinds of changes are permitted. A sec-
ond possibility is that escape from antibody neutralization
may not be a significant positive selection for H3N2 viruses
in vivo, and changes in the neutralizing antigenic sites may
be selected because they act in concert with other changes
in replication in order to generate more fit progeny, as
observed with recent human H3N2 isolates [43].
The specific kinds of changes observed in antigenic
sites in influenza B and H1 HAs, may also suggest that
the antibody repertoires specific for these sites is more
restricted than for H3N2 viruses, and thus a particular
type of change may be reflected in the antibody response
of many individuals. The primary anti-influenza antibody
response in humans may not be truly polyclonal, at least
against influenza B and H1 HAs. Instead, certain heavy
and/or light chain rearrangements and combinations
may be more likely to confer tight binding to individual
antigenic sites. Studies in humans vaccinated against
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is highly restricted, with some donors having only small
numbers of unique VH and VL rearrangements repre-
sented but showing evidence of significant diversification
due to somatic hypermutation [44]. Similarly, studies in
BALB/c mice immunized with influenza A/Puerto Rico/
8/34 (PR8) showed that certain heavy and light chain
genes, and particular VH-VL combinations were overre-
presented in the primary antibody response [45-47], with
more than 50% of the antibodies in the primary response
targetted to a particular antigenic site sharing a single VL
gene [46]. Interestingly, those antibodies most abundant
in the primary response were not as frequent in the sec-
ondary response, which showed a broader representation
of VH and VL genes. Thus, the apparent differences in
behavior we observe at different antigenic sites could
represent the effects of positive selection by a set of
primordial anti-influenza antibodies overrepresented in
the primary antibody response.
If positive selection by antibody does indeed play an im-
portant role, understanding how influenza virus persists in a
large and outbred population with a highly diverse immune
system, such as humans, presents something of a conun-
drum. The viruses circulating each year are closely related
both to each other and to the viruses circulating in the pre-
vious year. It has been suggested that certain individuals in
the population play a disproportionate role in the spread of
influenza [48]; such “superspreaders”, should they exist,
might also play a role as “superselectors” in modulating the
virus repertoire in the human population. The existence of
some sort of primordial antibody response where a particu-
lar VH, VL, or V(D)J rearrangement predominates would
also explain apparent differences in behavior between differ-
ent antigenic sites in the same molecule, since each anti-
genic site would be under the selection of a different set of
primordial antibodies that are consistent from individual to
individual. Thus, influenza viruses evolving to escape this
primordial response in one individual would now have a se-
lective advantage in other human hosts.
The role of antibody selection remains a critical open
question in understanding evolution of influenza virus in
the human population. Our data suggest that the relative
contribution of positive selection for antibody escape may
vary from subtype to subtype and site to site. Other data
suggest that there is a complex interplay between antigeni-
city and receptor utilization. For example, studies compar-
ing infection of immunized mice with mouse-adapted
influenza virus gave rise to numerous HA mutations which
simultaneously altered both receptor binding and antibody
neutralization [49]. Analyses of clinical H3N2 viruses from
2003 to 2008 indicated that these viruses had become pro-
gressively restricted in terms of the types of sialic acids
bound, correlating with a decreased requirement for recep-
tor-matched NA activity [50-52]. Since, as seen in HA,antigenic sites on NA are also located on the lip of the re-
ceptor binding pocket [8], adjustments in receptor binding
could either drive or result from changes in antigenicity of
HA, or even changes in NA. Finally, in the context of the
polyclonal antibody response, the role of alterations in virus
replication or innate immunity cannot be discounted [53].
Conclusions
We have attempted to integrate an understanding of the
role of protein structure and the thermodynamics of pro-
tein-protein interactions into evolutionary studies of in-
fluenza virus. Our studies indicate important and
surprising differences in the evolution of different influ-
enza HAs, and different antigenic sites within these
molecules in humans, possibly due to differences in the
immune response mounted to these viruses. Some anti-
genic sites show evidence that changes affecting specific
biophysical properties may play critical roles in selecting
novel influenza variants. Our findings may allow devel-
opment of models to predict, or at least assess the im-
portance of novel influenza strains in the future,
enhancing the effectiveness of vaccine design.
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